litlas
ログインアカウント作成

Henry Gómez

1991–2025 年に発表

別表記
Henry Gomez
107
論文数
24,553
被引用数
70
h 指数
103
i10 指数

被引用数

Henry Gómez の年別被引用数1981 年: 被引用 1 件1991 年: 被引用 2 件1997 年: 被引用 2 件1998 年: 被引用 1 件1999 年: 被引用 4 件2000 年: 被引用 11 件2001 年: 被引用 10 件2002 年: 被引用 4 件2003 年: 被引用 17 件2004 年: 被引用 13 件2005 年: 被引用 14 件2006 年: 被引用 22 件2007 年: 被引用 30 件2008 年: 被引用 60 件2009 年: 被引用 106 件2010 年: 被引用 127 件2011 年: 被引用 155 件2012 年: 被引用 162 件2013 年: 被引用 190 件2014 年: 被引用 178 件2015 年: 被引用 262 件2016 年: 被引用 238 件2017 年: 被引用 242 件2018 年: 被引用 291 件2019 年: 被引用 1,025 件2020 年: 被引用 1,034 件2021 年: 被引用 992 件2022 年: 被引用 802 件2023 年: 被引用 535 件2024 年: 被引用 962 件2025 年: 被引用 478 件2026 年: 被引用 19 件1982〜1990 年は被引用が無いため表示していません1992〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,965 件、この内訳の 24.9%中国: 引用元論文 1,131 件、この内訳の 9.5%イタリア: 引用元論文 743 件、この内訳の 6.2%イギリス: 引用元論文 675 件、この内訳の 5.7%ドイツ: 引用元論文 551 件、この内訳の 4.6%フランス: 引用元論文 495 件、この内訳の 4.2%スペイン: 引用元論文 416 件、この内訳の 3.5%カナダ: 引用元論文 371 件、この内訳の 3.1%スイス: 引用元論文 333 件、この内訳の 2.8%ベルギー: 引用元論文 332 件、この内訳の 2.8%オーストラリア: 引用元論文 324 件、この内訳の 2.7%オランダ: 引用元論文 256 件、この内訳の 2.1%
0%24.9%その他 27.9%

機関

分野

  • Medicine50.8%
  • Biochemistry, Genetics and Molecular Biology40.8%
  • Immunology and Microbiology2.4%
  • Computer Science1.9%
  • Engineering0.8%
  • Health Professions0.6%
  • その他2.7%

トピック

  • Breast Cancer Treatment Studies8.8%
  • HER2/EGFR in Cancer Research6%
  • Advanced Breast Cancer Therapies4.8%
  • Cancer Immunotherapy and Biomarkers4%
  • Cancer Genomics and Diagnostics3.3%
  • Cancer Cells and Metastasis2.5%
  • その他70.6%

共著者

全論文

検索で開く
  1. Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer

    著者: Nicholas C. Turner, Mafalda Oliveira, Sacha J. Howell, Florence Dalenc, Javier Cortés, Henry Gómez, Xichun Hu, Komal Jhaveri, Petr Krivorotko, Sibylle Loibl, Serafin Morales Murillo, Meena Okera, Yeon Hee Park, Joohyuk Sohn, Masakazu Toi, Eriko Tokunaga, Samih Yousef, Lyudmila Zhukova, Elza C. de Bruin, Lynda Grinsted, Gaia Schiavon, Andrew Foxley, Hope S. Rugo - New England Journal of Medicine 2023 被引用: 704

  2. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

    著者: Joseph A. Sparano, Robert J. Gray, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Peter M. Ravdin, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge - New England Journal of Medicine 2018 被引用: 2,369

  3. MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

    著者: Kyung‐min Lee, Jennifer M. Giltnane, Justin M. Balko, Luis J. Schwarz, Ángel Guerrero‐Zotano, Katherine E. Hutchinson, Mellissa J. Nixon, Mónica V. Estrada, Violeta Sánchez, Melinda E. Sanders, Taekyu Lee, Henry Gómez, Aňa Lluch, José Alejandro Pérez Fidalgo, Melissa M. Wolf, Gabriela Andrejeva, Jeffrey C. Rathmell, Stephen W. Fesik, Carlos L. Arteaga - Cell Metabolism 2017 被引用: 646

  4. Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer

    著者: Rinath Jeselsohn, Roman Yelensky, Gilles Buchwalter, Garrett M. Frampton, Funda Meric‐Bernstam, Ana M. González-Angulo, Jaime Ferrer-Lozano, José Alejandro Pérez Fidalgo, Massimo Cristofanilli, Henry Gómez, Carlos L. Arteaga, Jennifer M. Giltnane, Justin M. Balko, Maureen Cronin, Mirna Jarosz, James Sun, Matthew Hawryluk, Doron Lipson, Geoff Otto, Jeffrey S. Ross, Addie Dvir, Lior Soussan‐Gutman, Ido Wolf, Tamar Rubinek, Lauren Gilmore, Stuart J. Schnitt, Steven E. Come, Lajos Pusztai, Philip Stephens, Myles Brown, Vincent A. Miller - Clinical Cancer Research 2014 被引用: 662

  5. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

    著者: Prudence A. Francis, Olivia Pagani, Gini F. Fleming, Barbara Walley, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Eva Ciruelos, Harold J. Burstein, Hervé Bonnefoi, Meritxell Bellet, Silvana Martino, Charles E. Geyer, Matthew P. Goetz, Vered Stearns, Graziella Pinotti, Fabio Puglisi, Simon Spazzapan, Miguel Ángel Climent, Lorenzo Pavesi, Thomas Ruhstaller, Nancy E. Davidson, Robert L. Coleman, Marc Debled, Stefan Buchholz, James N. Ingle, Eric P. Winer, Rudolf Maibach, Manuela Rabaglio, Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 被引用: 673

  6. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

    著者: José Baselga, Ian Bradbury, Holger Eidtmann, Serena Di Cosimo, Evandro de Azambuja, Claudia Aura, Henry Gómez, Phuong Dinh, Karine Fauria, Veerle Van Dooren, Gursel Aktan, Aron Goldhirsch, Tsai-Wang Chang, Zsolt Horváth, M.A. Coccia-Portugal, Julien Dômont, Ling-Min Tseng, Georg Kunz, Joohyuk Sohn, Semiglazov Vf, Guillermo Lerzo, Markéta Palácová, Volodymyr Probachai, Lajos Pusztai, Michael Untch, Richard D. Gelber, Martine Piccart - The Lancet 2012 被引用: 1,314

  7. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    著者: Olivia Pagani, Barbara Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Harold J. Burstein, Matthew P. Goetz, Eva Ciruelos, Vered Stearns, Hervé Bonnefoi, Silvana Martino, Charles E. Geyer, Claudio Chini, Fabio Puglisi, Simon Spazzapan, Thomas Ruhstaller, Eric P. Winer, Barbara Ruepp, Sherene Loi, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan, Prudence A. Francis - Journal of Clinical Oncology 2022 被引用: 154

  8. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

    著者: Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge - New England Journal of Medicine 2019 被引用: 555

  9. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

    著者: Joseph A. Sparano, Robert J. Gray, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Edith A. Perez, John A. Olson, JoAnne Zujewski, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Peter M. Ravdin, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, James N. Atkins, Jeffrey L. Berenberg, George W. Sledge - New England Journal of Medicine 2015 被引用: 1,439

  10. RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

    著者: Sherene Loi, Sathana Dushyanthen, Paul A. Beavis, Roberto Salgado, Carsten Denkert, Peter Savas, S.E. Combs, David L. Rimm, Jennifer M. Giltnane, Mónica V. Estrada, Violeta Sánchez, Melinda E. Sanders, Rebecca S. Cook, Mark A. Pilkinton, S. Mallal, Kai Wang, Vincent A. Miller, Phil Stephens, Roman Yelensky, Franco D. Doimi, Henry Gómez, Sergey Ryzhov, Phillip K. Darcy, Carlos L. Arteaga, Justin M. Balko - Clinical Cancer Research 2015 被引用: 552

  11. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

    著者: Olivia Pagani, Meredith M. Regan, Barbara Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Harold J. Burstein, Edith A. Perez, Eva Ciruelos, Vered Stearns, Hervé Bonnefoi, Silvana Martino, Charles E. Geyer, Graziella Pinotti, Fabio Puglisi, Diana Crivellari, Thomas Ruhstaller, Eric P. Winer, Manuela Rabaglio, Rudolf Maibach, Barbara Ruepp, Anita Giobbie‐Hurder, Karen N. Price, Jürg Bernhard, Weixiu Luo, Karin Ribi, Giuseppe Viale, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Prudence A. Francis - New England Journal of Medicine 2014 被引用: 747

  12. NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    著者: Brandie C. Taylor, Xiaopeng Sun, Paula I. González-Ericsson, Violeta Sánchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gómez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa‐Maria, Payal D. Shah, Elizabeth Claire Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko - Cancer Discovery 2023 被引用: 63

  13. PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

    著者: Brian D. Lehmann, Joshua A. Bauer, Johanna M. Schafer, Christopher S Pendleton, Luojia Tang, Kimberly C. Johnson, Xi Chen, Justin M. Balko, Henry Gómez, Carlos L. Arteaga, Gordon B. Mills, Melinda E. Sanders, Jennifer A. Pietenpol - Breast Cancer Research 2014 被引用: 331

  14. Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

    著者: Stephen Johnston, John Pippen, Xavier Pivot, Mikhail Lichinitser, Saeed Sadeghi, Véronique Dièras, Henry Gómez, Gilles Romieu, Alexey Manikhas, M. John Kennedy, Michael F. Press, J. Maltzman, Allison Florance, Lisa O’Rourke, Cristina Oliva, Steven Stein, Mark D. Pegram - Journal of Clinical Oncology 2009 被引用: 1,024

  15. Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

    著者: Halle C. F. Moore, Joseph M. Unger, Kelly‐Anne Phillips, Frances Boyle, Erika Hitre, David Porter, Prudence A. Francis, Lori J. Goldstein, Henry Gómez, Carlos Vallejos, Ann H. Partridge, Shaker R. Dakhil, Agustin A. García, Julie R. Gralow, Janine Lombard, John Forbes, Silvana Martino, William E. Barlow, Carol J. Fabian, Lori M. Minasian, Frank L. Meyskens, Richard D. Gelber, Gabriel N. Hortobágyi, Kathy S. Albain - New England Journal of Medicine 2015 被引用: 542

  16. Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

    著者: Justin M. Balko, Jennifer M. Giltnane, Kai Wang, Luis J. Schwarz, Christian D. Young, Rebecca S. Cook, Philip Owens, Melinda E. Sanders, María G. Kuba, Violeta Sánchez, Richard Kurupi, Preston D. Moore, Joseph A. Pinto, Franco D. Doimi, Henry Gómez, Dai Horiuchi, Andrei Goga, Brian D. Lehmann, Joshua A. Bauer, Jennifer A. Pietenpol, Jeffrey S. Ross, Gary A. Palmer, Roman Yelensky, Maureen Cronin, Vincent A. Miller, P. J. Stephens, Carlos L. Arteaga - Cancer Discovery 2013 被引用: 477

  17. Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer

    著者: Paula I. González-Ericsson, Julia D. Wulfkhule, Rosa I. Gallagher, Xiaopeng Sun, Margaret L. Axelrod, Quanhu Sheng, Na Luo, Henry Gómez, Violeta Sánchez, Melinda E. Sanders, Lajos Pusztai, Emanuel Petricoin, Kim Blenman, Justin M. Balko, I-SPY2 Trial Team - Clinical Cancer Research 2021 被引用: 91

  18. Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

    著者: Olivia Pagani, Prudence A. Francis, Gini F. Fleming, Barbara Walley, Giuseppe Viale, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Graziella Pinotti, Angelo Di Leo, Alan S. Coates, Aron Goldhirsch, Richard D. Gelber, Meredith M. Regan, for the SOFT and TEXT Investigators and International Breast Cancer Study Group - Journal of Clinical Oncology 2019 被引用: 150

  19. Genomic profiling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance

    著者: Jennifer M. Giltnane, Katherine E. Hutchinson, Thomas Stricker, Luigi Formisano, Christian D. Young, Mónica V. Estrada, Mellissa J. Nixon, Liping Du, Violeta Sánchez, Paula I. González-Ericsson, María G. Kuba, Melinda E. Sanders, Xinmeng Jasmine Mu, Eliezer M. Van Allen, Nikhil Wagle, Ingrid A. Mayer, Vandana G. Abramson, Henry Gómez, Monica Rizzo, Weiyi Toy, Sarat Chandarlapaty, Erica L. Mayer, Jason Christiansen, Danielle Murphy, Kerry Fitzgerald, Kai Wang, Jeffrey S. Ross, Vincent A. Miller, P. J. Stephens, Roman Yelensky, Levi A. Garraway, Yu Shyr, Ingrid M. Meszoely, Justin M. Balko, Carlos L. Arteaga - Science Translational Medicine 2017 被引用: 124

  20. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?

    著者: Joseph A. Pinto, Carlos Vallejos, Luis E. Raez, Luís Más, Rossana Ruiz, J. Smith Torres‐Roman, Zaida Morante, Jhajaira M. Araujo, Henry Gómez, Alfredo Aguilar, Denisse Bretel, Claudio Flores, Christian Rolfo - ESMO Open 2018 被引用: 168

  21. A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

    著者: Omid Hamid, Henrik Schmidt, Aviram Nissan, Laura Ridolfi, Steinar Aamdal, Johan Hansson, Michele Guida, David M. Hyams, Henry Gómez, Lars Bastholt, Scott D. Chasalow, David M. Berman - Journal of Translational Medicine 2011 被引用: 531

  22. Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

    著者: Joanne L. Blum, Patrick J. Flynn, Greg Yothers, Lina Asmar, Charles E. Geyer, Samuel A. Jacobs, Nicholas J. Robert, Judith O. Hopkins, Joyce O’Shaughnessy, Chau T. Dang, Henry Gómez, Louis Fehrenbacher, Svetislava J. Vukelja, Alan P. Lyss, Devchand Paul, Adam Brufsky, Jong‐Hyeon Jeong, Linda H. Colangelo, Sandra M. Swain, Eleftherios P. Mamounas, Stephen E. Jones, Norman Wolmark - Journal of Clinical Oncology 2017 被引用: 288

  23. Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer

    著者: Justin M. Balko, Luis J. Schwarz, Neil E. Bhola, Richard Kurupi, Philip Owens, Todd W. Miller, Henry Gómez, Rebecca S. Cook, Carlos L. Arteaga - Cancer Research 2013 被引用: 163

  24. Planning cancer control in Latin America and the Caribbean

    著者: Paul E. Goss, Brittany Lee, Tanja Badovinac-Črnjević, Kathrin Strasser‐Weippl, Yanin Chávarri-Guerra, Jessica St. Louis, Cynthia Villarreal‐Garza, Karla Unger‐Saldaña, Mayra Ferreyra, Márcio Debiasi, Pedro ER Liedke, Diego Touya, Gustavo Werutsky, Michaela J. Higgins, Lei Fan, Cláudia Cristina Ferreira Vasconcelos, Eduardo Cazap, Carlos Vallejos, Alejandro Mohar, Felícia Marie Knaul, Héctor Arreola, Rekha Batura, Silvana Luciani, Richard Sullivan, Dianne M. Finkelstein, Sérgio D. Simon, Carlos H. Barrios, Rebecca S Kightlinger, Andrés Gelrud, Brittany Bychkovsky, Gilberto Lopes, Stephen Stefani, Marcelo Blaya, Fabiano Hahn Souza, Franklin Santana Santos, Alberto Kaemmerer, Evandro de Azambuja, Andres Felipe Cardona Zorilla, Raúl Murillo, José Jerónimo, Vivien Tsu, André Lopes Carvalho, Carlos Ferreira Gil, Cinthya Sternberg, Alfonso Dueñas‐González, Dennis C. Sgroi, Mauricio Cuello, Rodrigo Fresco, Rui Manuel Reis, Guiseppe Masera, Raúl Gabus, Raul C. Ribeiro, Renata Erthal Knust, Gustavo Ismael, Eduardo Rosenblatt, Berta Roth, Luisa L. Villa, Argelia Lara Solares, Marta León, Isabel Torres‐Vigil, Alfredo Covarrubias‐Gómez, Andrés Hernández, Mariela Bertolino, Gilberto Schwartsmann, Sergio Santillana, Francisco J. Esteva, Luis Fein, Max S. Mano, Henry Gómez, Marc Hurlbert, Alessandra Durstine, Gustavo S. Azenha - The Lancet Oncology 2013 被引用: 504